Abstract

South Africa has the highest incidence of drug resistant-tuberculosis (DR-TB) in sub-Saharan Africa and outcomes are poor. Only 54% of patients successfully complete treatment. The prevalence of HIV co-infection and cardiovascular (CVD) risk factors is also increasing. The purpose of this study was to describe cardiovascular risk in DR-TB patients with and without HIV co-infection and the impact of this risk on 6-month DR-TB negative treatment outcomes among patients co-infected with HIV.

Author Details

Erin Rachel Whitehouse, PhD, MPH, RN

Sigma Membership

Nu Beta at-Large

Type

Dissertation

Format Type

Text-based Document

Study Design/Type

Cohort

Research Approach

Quantitative Research

Keywords:

Tuberculosis, Drug-Resistance, Cardiovascular Risk, Cardiovascular Risk Factors, Smoking, HIV

Advisor

Jason E. Farley

Degree

PhD

Degree Grantor

Johns Hopkins University

Degree Year

2018

Rights Holder

All rights reserved by the author(s) and/or publisher(s) listed in this item record unless relinquished in whole or part by a rights notation or a Creative Commons License present in this item record.

All permission requests should be directed accordingly and not to the Sigma Repository.

All submitting authors or publishers have affirmed that when using material in their work where they do not own copyright, they have obtained permission of the copyright holder prior to submission and the rights holder has been acknowledged as necessary.

Review Type

None: Degree-based Submission

Acquisition

Self-submission

Date of Issue

2018-05-10

Full Text of Presentation

wf_yes

Download

Share

COinS